Luca Barattini

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Knee Osteoarthritis

Top Venues

JMIR research protocols

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor
Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:). JMIR research protocols 13 (2024)
Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor
Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:). JMIR research protocols 13 (2024)
Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor
Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:). JMIR research protocols 13 (2024)
Fabio Cardinale, Dionisio Franco Barattini, Valentina Martinucci, Maria Morariu Bordea, Luca Barattini, Serban Rosu
The Effectiveness of a Dietary Supplement with Honey, Propolis, Pelargonium sidoides Extract, and Zinc in Children Affected by Acute Tonsillopharyngitis: An Open, Randomized, and Controlled Trial. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Fabio Cardinale, Dionisio Franco Barattini, Valentina Martinucci, Maria Morariu Bordea, Luca Barattini, Serban Rosu
The Effectiveness of a Dietary Supplement with Honey, Propolis, Pelargonium sidoides Extract, and Zinc in Children Affected by Acute Tonsillopharyngitis: An Open, Randomized, and Controlled Trial. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)